Age-related changes in cerebral blood flow and glucose metabolism in conscious rhesus monkeys

Brain Research

Volumn 936, Issue 1-2, 2002, Pages 76-81

  Noda, Akihiro ^a,c   Ohba, Hiroyuki ^b   Kakiuchi, Takeharu ^b   Futatsubashi, Masami ^b   Tsukada, Hideo ^b   Nishimura, Shintaro ^a,c  

^a ASTELLAS PHARMA INC   (Japan)

^b CENTRAL RESEARCH LABORATORY   (Japan)

^c Medical and Pharmacological Research Center Foundation   (Japan)

Author keywords

Aging; Cerebral blood flow; Cerebral metabolic rate of glucose; Positron emission tomography; Rhesus monkey

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; WATER O 15;

AGED; AGING; ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; CEREBELLUM; CONSCIOUSNESS; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; MACACA; MALE; METABOLIC RATE; NONHUMAN; OCCIPITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHESUS MONKEY; TEMPORAL CORTEX;

AGING; ANIMALS; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; CONSCIOUSNESS; ENERGY METABOLISM; GLUCOSE; MACACA MULATTA; MALE; NEURONS; STATISTICS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037123756     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02558-1     Document Type: Article

References (41)

1. Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography
2. Positron emission tomography in aging and dementia: Effect of cerebral atrophy
3. Age-related changes in brain: II. Positron emission tomography of frontal and temporal lobe glucose metabolism in normal subjects
4. Post-mortem regional neurofibrillary tangle densities but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer's disease patients
5. Positron emission tomography in Alzheimer's disease
6. PET studies of cerebral glucose metabolism in conscious rhesus macaques
7. Cerebral glucose metabolism and memory in aged rhesus macaques
8. Cerebral normoxia in the rhesus monkey during isoflurane- or propofol-induced hypotension and hypocapnia, despite disparate blood-flow patterns. A positron emission tomography study
9. Pathological and positron emission tomographic correlations in Alzheimer's disease
10. Emission tomographic measurement of local cerebral blood flow in humans by an in vivo autoradiographic strategy
11. The effects of apomorphine upon local cerebral glucose utilization in conscious rats and in rats anesthetized with chloral hydrate
12. Tacrine treatment in Alzheimer's disease enhances cerebral blood flow and mental status and decreases caregiver suffering
13. Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis
14. Clinical studies of cerebral blood flow in Alzheimer's disease
15. Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method
16. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age
17. Regional cerebral function determined by FDG-PET in healthy volunteers: Normal patterns and changes with age
18. Predominant left hemisphere metabolic dysfunction in dementia
19. Decreases in regional cerebral blood flow with normal aging
20. Direct cerebral vasodilatory effects of sevoflurane and isoflurane
21. Direct cerebrovasodilatory effects of halothane, isoflurane, and desflurane during propofol-induced isoelectric electroencephalogram in humans
22. Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis)
23. Posterior cingulate cortex in Alzheimer's disease
24. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
25. Predicting cognitive decline in Alzheimer's disease using positron emission tomography
26. Regional cerebral blood flow during development and ageing of the rat brain
27. Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: Positron emission tomography study using conscious rhesus monkey
28. Regional cerebral blood flow and oxygen consumption in human aging
29. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method
30. Alzheimer's disease-type brain abnormalities in animal models
31. Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation
32. Glucose metabolic rate kinetic model parameter determination in humans: The lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose
33. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system
34. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat
35. Brain activation study by use of positron emission tomography in unanesthetized monkeys
36. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: Multiparametric PET studies combined with microdialysis analysis
37. Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: A PET study in conscious monkeys
38. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain
39. Age-related impairment of coupling mechanism between neuronal activation and functional cerebral blood flow response was restored by cholinesterase inhibition: PET study with microdialysis in the awake monkey brain
40. A high resolution animal PET scanner using compact PS-PMT detectors
41. Symposium summary. Neuronal activity and energy metabolism